Thirty-five percent of type 2 diabetes patients who initially experienced disease remission following gastric bypass surgery redeveloped diabetes within five years, while many patients never attained remission after the procedure, a study in Obesity Surgery found. Surgery appeared to be most effective for type 2 diabetes patients without advanced disease, researchers said.
Gastric bypass might not have long-term benefits in diabetes
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|